Hematology
From the Journals
Blood biomarkers predict TBI disability and mortality
Measuring glial fibrillary acidic protein and ubiquitin carboxy-terminal hydrolase L1 proteins may give a more accurate assessment of a patient’s...
News from the FDA/CDC
FDA approves first gene therapy, betibeglogene autotemcel (Zynteglo), for beta-thalassemia
The one-time gene therapy represents a potential cure in which functional copies of the mutated gene are inserted into patients’ hematopoietic...
From the Journals
No more injections after one-off gene therapy in hemophilia B
“Normal factor IX levels can be achieved in patients with severe or moderately severe hemophilia B with the use of relatively low vector doses of...
Guidelines
Evidence still lacking that vitamins prevent CVD, cancer: USPSTF
In its final recommendation statement on the subject, the task force does, however, recommend against use of vitamin E and beta-carotene.
Opinion
Patients with blood cancers underutilize palliative care
Today in “Diminutio,” Sarah D’Ambruoso, NP, highlights this and other key presentations on palliative care from the ASCO annual meeting.
Guidelines
Updated AHA/ASA guideline changes care for spontaneous intracerebral hemorrhage
Several “standard care” therapies for ICH are not as effective as once thought and are no longer recommended in updated guidelines.
From the Journals
Cancer patients unaware of their increased thrombosis risk
“These professionals are on the front line of the battle; they are among the first healthcare workers given the chance to suspect a clot and...
Conference Coverage
Novel COVID-19 vaccine could fill the void for patients with blood cancers
Existing vaccines provide weak protection for immunocompromised patients with B-cell deficiencies.
Feature
Rare pediatric cancers persist 63 years after nuclear accident
Near Los Angeles, the parents of kids whose cluster of rare leukemias and other cancers may be linked to a 1959 partial meltdown at Santa Susana...
Latest News
Complex link between gut microbiome and immunotherapy response in advanced melanoma
Previous studies have identified the gut microbiome as “a potential biomarker of response as well as a therapeutic target” in melanoma and other...
From the Journals
More exercise for people with hemophilia, experts advise
Physical activity can improve “quality of life” in people with hemophilia.